Home » Stocks » AXIM

AXIM Biotechnologies, Inc. (AXIM)

Stock Price: $0.6700 USD -0.0670 (-9.09%)
Updated May 14, 2021 3:57 PM EDT - Market closed
Market Cap 86.34M
Revenue (ttm) 799,483
Net Income (ttm) -6.41M
Shares Out 128.86M
EPS (ttm) -0.06
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 14
Last Price $0.6700
Previous Close $0.7370
Change ($) -0.0670
Change (%) -9.09%
Day's Open 0.7400
Day's Range 0.6250 - 0.7400
Day's Volume 133,369
52-Week Range 0.1300 - 1.2700

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

SAN DIEGO, May 05, 2021 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological and ...

1 week ago - GlobeNewsWire

SAN DIEGO, May 03, 2021 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc . (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological and...

1 week ago - GlobeNewsWire

SAN DIEGO, March 24, 2021 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological an...

1 month ago - GlobeNewsWire

SAN DIEGO, March 08, 2021 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological an...

2 months ago - GlobeNewsWire

SAN DIEGO, Jan. 11, 2021 (GLOBE NEWSWIRE) -- AXIM ®  Biotechnologies, Inc .  (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological...

4 months ago - GlobeNewsWire

About AXIM

AXIM Biotechnologies, Inc., a preclinical stage research and development company focuses on changing diagnosis and treatment for oncology and SARS-CoV-2 (COVID-19). The company is developing NeuCovix, a rapid diagnostic test measuring levels of functional neutralizing antibodies to prevent SARS-CoV-2 from entering the host cells; and ImmunoPass, a rapid serological diagnostic test that measures SARS-CoV-2 neutralizing antibodies within 10 minutes. It is also developing rapid diagnostic tests for the early detection of cancer and proprietary sma... [Read more...]

Industry
Biotechnology
Founded
2010
Stock Exchange
OTCMKTS
Ticker Symbol
AXIM
Full Company Profile

Financial Performance

Financial Statements